在线客服 
点击这里给我发消息
 
   
400-0909-005
  021-69955236

产品类别
 TCI
 配制试剂
 离子对试剂
 离子对试剂
 配制试剂
 TCI
 新品推荐
 新品推荐
 色素
 色素
 酶和辅酶
 酶和辅酶
 对照品
 对照品
 核苷酸类
 核苷酸类
 抗生素类
 抗生素类
 植物生长激素类
 植物生长激素类
 抗生素,生物碱
 抗生素,生物碱
 培养基类
 培养基类
 维生素类
 维生素类
 蛋白类
 蛋白类
 糖类
 糖类
 碳水化合物
 碳水化合物
 氨基酸
 氨基酸
 缓冲液
 缓冲液
 葡聚糖凝胶
 葡聚糖凝胶
 常用色谱类试剂
 常用色谱类试剂
 实验室常用耗材
 实验室常用耗材
 其他类
 其他类
 奎宁系列
 奎宁系列
推荐产品
新闻中心
Clinical Trials of Induced Bone Regeneration Devices to Begin–Aiming for Commercialization as a Next-Generation Bone Reconstruction Material– (This news was published in Japanese on Apr. 13, 2015)
         
Osaka, Japan, April 13, 2015 - Tohoku University (located in Sendai, Miyagi Prefecture, President: Susumu Satomi) has been developing induced bone regeneration devices based on an octacalcium phosphate-collagen complex (hereinafter, OCP/Collagen).This is a next-generation bone reconstruction material that is injected into the damaged portion of bones and induces new bone growth.
Toyobo has been working toward the commercialization of OCP/Collagen, and clinical trials for use of this material in dental and oral surgery domains will begin in early June 2015.

Uteam-BIOTECH
   隐私政策   使用须知   销售条款及条件   售后服务   GHS危&防范声明
   上海跃腾生物科技有限公司UTEAM(SH)         沪ICP备16052474号-1